Two enzymes which phosphorylate neomycin and kanamycin have been detected in Escherichia coli strains carrying R factors. Neomycin-kanamycin phosphotransferase I can phosphorylate neomycin and kanamycin, but not butirosin. Neomycin-kanamycin phosphotransferase II can phosphorylate all three antibiotics. The enzymes also differ in their response to certain inhibitors of phosphorylation. Neomycin-kanamycin phosphotransferase II is found in certain strains of Pseudomonas aerugtnosa.
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Phosphorylation of aminoglycoside antibiotics (neomycin, kanamycin, and paromomycin) is a common form of inactivation in many resistant strains of Echerichia coli, Klebsla pneumoniae, Pseudomnas aeruginosa, and Staphylococcus aureus (4, 7) . Enzymes (neomycin-kanamycin phosphotransferases) have been isolated which catalyze the phosphorylation of these compounds; in E. coli, K. pneumoniae, and P. aeruginosa, the synthesis of the enzymes is determined extrachromosomally by R factors (3, 7) . Umezawa and his colleagues in an extensive series of studies (8) have characterized inactivated neomycin and kanamycin and have shown them to be modified on the 3W-hydroxyl group of the 6-or 2,6-glucosamine ring ( Fig. 1 and 2) .
Woo et al. (6, 11) recently described the new aminoglycoside antibiotic butirosin (Fig. 3) , a member of the neomycin family, closely related to ribostamycin (1) . In screening several Rfactor-containing E. coli strains for susceptibility to butirosin, it was found that some of the strains capable of phosphorylating neomycin and kanamycin were susceptible to butirosin whereas others were resistant (K. E. Price, personal communication Enzymatic assays. Phosphorylation of aminoglycoside antibiotics was assayed by the phosphocellulose paper binding assay, as described previously (9) .
Enzyme preparation. Crude enzyme preparations were obtained from R factor-carrying E. coli strains after osmotic shock (2, 9) . Further purification was carried out by precipitation of nucleic acids with streptomycin sulfate and chromatography on diethylaminoethyl (DEAE)-cellulose (Whatman DE 32). The columns were eluted with an increasing gradient of ammonium chloride (O to 0.3 M) in tris(hydroxymethyl)aminomethane buffer, pH 7.5, containing 10 mg of neomycin B/ liter. The addition of neomycin stabilizes the enzyme during storage. The enzymes elute at an ammonium chloride concentration of 0.13 to 0.2 M. On occasion, these enzymes were purified further by chromatography on hydroxylapatite (Bio-Gel HT); elution was carried out with potassium phosphate.
Neomycin-kanamycin phosphotransferase from P. aeruginosa Ps49 was purified in essentially the 
RESULTS
Resistance of bacterial strains to aminoglycoside antibiotics. The spectra of resistance of the two E. coli R-factor-carrying strains are shown in Table 1 . The only differences between these strains, in their response to aminoglycoside antibiotics which can be phosphorylated at the 3'-hydroxyl, is that E. coli JR66 is resistant to butirosins A and B whereas E. coli JR39 is susceptible to this antibiotic. E. coli JR66 is also resistant to gentamicin, chloramphenicol, tetracycline, and streptomycin; E. coli JR39 is resistant to tetracycline and streptomycin. The presence of R factors in these strains has been demonstrated by conjugal transfer of resistance determinants from E. coli JR66 and E. coli JR39 to an antibiotic-susceptible recipient strain. E. coli JR66 probably carries two different R factors. The genes determining neomycin-kanamycinphosphotransferase II and streptomycin phosphotransferase in this strain are transferred at high frequency; the other resistance determinants (gentamicin, chloramphenicol, and tetracycline) are transferred at a much lower frequency (unpublished data). P. aeruginosa Ps49 is highly resistant to neomycin and kanamycin, but it is not known whether these resistance characters are associated with a plasmid. R-factor-determined neomycin-kanamycin resistance has been demonstrated in some strains of P. aeruginosa (3, 10) .
Properties of neomycin-kanamycin phosphotransferases. The substrate range of the neomycin-kanamycin phosphorylating enzymes isolated from E. coli JR66, E. coli JR39, and P. aerugino8a Ps49 are shown in Table 2 . The antibiotics of the butirosin group acted as substrates for the phosphorylating enzymes from E. coli JR66 and P. aeruginosa Ps49, but not for the enzyme from E. coli JR39. None of the enzymes could phosphorylate gentamicin Cl. or tobramycin, both of which lack the 3'-hydroxyl group which is the site of phosphorylation. In addition, the semisynthetic antibiotic BBK-8, which is N-(4-amino-2-hydroxy-butyryl)-kanamycinA,was not phosphorylated by these enzymes.
We have previously noted that gentamicin C1. and tobramycin can inhibit the phosphorylation of neomycin by the neomycin-kanamycin phosphotransferase of E. coli JR39 (4, 5) . When these inhibitors were used with the enzymes from E. coli JR66 and P. aeruginosa Ps49, little or no inhibition was detected when amounts of gentamicin Cl. or tobramycin equal to the amount of substrate (neomycin) were present in the reaction mixture (Table 3) . With kanamycin C as substrate, tobramycin was the most effective inhibitor (Table 4 ). This suggests that we are observing competitive inhibition, since tobramycin, structurally, is more closely related to kanamycin C than is gentamicin Cl1 .
Attempts to show gross differences between VOL. 3, 1973 on June 18, 2017 by guest http://aac.asm.org/ a Activities are expressed relative to neomycin as 100% (100% = 2,000 to 5,000 counts per min per assay). Assays were carried out as described previously (9) in an incubation volume of 50 pliters with adenosine triphosphate-y32P as substrate. Antibiotics were used at a final concentration of 200 ,Ag/ml. 
